Cargando…

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke

BACKGROUND: Adiponectin plays role in multiple metabolic pathways. Previous studies in cardiovascular disease evaluated the association between adiponectin and clinical outcomes, yielding conflicting results. The aim of this study was to investigate the association of adiponectin with major adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Wen-Jun, Qiu, Han-Cheng, Liu, Ya-Kun, Liu, Qiang, Zeng, Xianwei, Zhao, Jizong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415178/ https://www.ncbi.nlm.nih.gov/pubmed/32771014 http://dx.doi.org/10.1186/s12933-020-01096-3

Ejemplares similares

The association between serum adiponectin and 3-month outcome after ischemic stroke
por: Wang, Zengliang, et al.
Publicado: (2019)

Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction
por: Guo, Wen, et al.
Publicado: (2023)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA
por: Carlsson, Andreas, et al.
Publicado: (2023)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
por: Barbosa, Carlos J.D.G., et al.
Publicado: (2019)

Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events
por: Wang, Anxin, et al.
Publicado: (2021)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population
por: Li, Suying, et al.
Publicado: (2019)

Adiponectin, diabetes and ischemic heart failure: a challenging relationship
por: Baldasseroni, Samuele, et al.
Publicado: (2012)

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
por: Tsai, Chuan-Tsai, et al.
Publicado: (2020)

Assessing risk factors for major adverse cardiovascular and cerebrovascular events during the perioperative period of carotid angioplasty with stenting patients
por: Liu, Juan, et al.
Publicado: (2016)

Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
por: Fu, Liyao, et al.
Publicado: (2021)

Cardio‐ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients
por: Limpijankit, Thosaphol, et al.
Publicado: (2021)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Assessment of the Role of Carotid Atherosclerosis in the Association Between Major Cardiovascular Risk Factors and Ischemic Stroke Subtypes
por: Parish, Sarah, et al.
Publicado: (2019)

Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction
por: Wang, Qian, et al.
Publicado: (2017)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Sex differences in major adverse cardiovascular and cerebrovascular event risk among central retinal artery occlusion patients
por: Chen, Ting, et al.
Publicado: (2023)

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
por: Xing, Zhenhua, et al.
Publicado: (2020)

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension
por: Wang, Xiaopu, et al.
Publicado: (2021)

Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
por: Chen, Guanmin, et al.
Publicado: (2021)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Risk factors of short-term stroke recurrence in patients with minor ischemic cerebrovascular events
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up
por: Kręcki, Radosław, et al.
Publicado: (2011)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension
por: Jiao, Jie, et al.
Publicado: (2022)

Ischemic Brain Lesions After Carotid Artery Stenting Increase Future Cerebrovascular Risk
por: Gensicke, Henrik, et al.
Publicado: (2015)

Associations of Warfarin Use with Risks of Ischemic Cerebrovascular Events and Major Bleeding in Patients with Hyperthyroidism-Related Atrial Fibrillation
por: Liu, Sian-De, et al.
Publicado: (2022)

Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors
por: Pasi, Marco, et al.
Publicado: (2022)

Tumor Necrosis Factor-α: The Next Marker of Stroke
por: Xue, Yimeng, et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

Underestimated Ischemic Heart Disease in Major Adverse Cardiovascular Events after Septicemia Discharge
por: Hsiao, Chih-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_873in0u8tmqno2866lpq2i5j5a